HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid → HCID 178432521, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid | HCID 7127808 | — |
| Reactant | HCID 178478710 | HCID 178478710 | — |
| Product | HCID 178432521 | HCID 178432521 | — |
Reaction Steps
The title compound, white solid (98 mg, 77%), MS (ISP) m/z=515.4 [(M+H)+], mp 256.5° C., was prepared in accordance with the general method of example 1 from trans-4-{2-[4-(2,3-dihydro-benzofuran-4-yl)-piperidin-1-yl]-ethyl}-cyclohexylamine dihydro chloride (intermediate B) (100 mg, 0.25 mmol) and 4-(5-methyl-[1,2,4]oxadiazol-3-yl)-benzoic acid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08877778B2 |
| Source dataset | uspto-grants-2014_11 |
| ORD ID | ord-5a6289c8eae04ede825eac131e83d0dc |
| Source note | uspto-grants-2014_11 |